Cardiovascular Research

雜志介紹

Cardiovascular Research雜志介紹

《Cardiovascular Research》是一本以English為主的未開放獲取國(guó)際優(yōu)秀期刊，中文名稱心血管研究，本刊主要出版、報(bào)道醫(yī)學(xué)-CARDIAC & CARDIOVASCULAR SYSTEMS領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為10.2，最新CiteScore 指數(shù)為21.5。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Deciphering endothelial heterogeneity in health and disease at single-cell resolution: progress and perspectives

  Author: Becker, Lisa M.; Chen, Shiau-Haln; Rodor, Julie; de Rooij, Laura P. M. H.; Baker, Andrew H.; Carmeliet, Peter

• RNF207 exacerbates pathological cardiac hypertrophy via post-translational modification of TAB1

  Author: Yuan, Lin; Bu, Shichen; Du, Meng; Wang, Yilong; Ju, Chenhui; Huang, Dandan; Xu, Wenjing; Tan, Xin; Liang, Minglu; Deng, Shan; Yang, Liu; Huang, Kai

• Eosinophils protect pressure overload- and beta-adrenoreceptor agonist-induced cardiac hypertrophy

  Author: Yang, Chongzhe; Li, Jie; Deng, Zhiyong; Luo, Songyuan; Liu, Jing; Fang, Wenqian; Liu, Feng; Liu, Tianxiao; Zhang, Xian; Zhang, Yuanyuan; Meng, Zhaojie; Zhang, Shuya; Luo, Jianfang; Liu, Conglin; Yang, Dafeng; Liu, Lijun; Sukhova, Galina K.; Sadybekov, Anastasiia; Katritch, Vsevolod; Libby, Peter; Wang, Jing; Guo, Junli; Shi, Guo-Ping

• Ryanodine receptor 2 (RYR2) dysfunction activates the unfolded protein response and perturbs cardiomyocyte maturation

  Author: Guo, Yuxuan; Cao, Yangpo; Jardin, Blake D.; Zhang, Xiaoran; Zhou, Pingzhu; Guatimosim, Silvia; Lin, Junsen; Chen, Zhan; Zhang, Yueyang; Mazumdar, Neil; Lu, Fujian; Ma, Qing; Lu, Yao-Wei; Zhao, Mingming; Wang, Da-Zhi; Dong, Erdan; Pu, William T.

英文介紹

Cardiovascular Research雜志英文介紹

Cardiovascular Research is the international journal of the European Society of Cardiology for basic and translational research, spanning all topics within cardiology and cardiovascular biology. The journal aims to enhance insight into cardiovascular disease mechanisms and the prospects for innovation. The journal welcomes submission of papers both at the molecular, sub-cellular, cellular, organ, and organism level, and of clinical proof-of-concept and translational studies. Manuscripts are expected to provide a significant contribution to the field with relevance for cardiovascular biology and diseases.